SEC 13F Intelligence

EMERALD BIOSCIENCE INC

CUSIP 29102Y101

Emerald Bioscience Inc has 1 institutional holders in Filings Flow’s 13F database, together reporting 14.48M shares worth $579,000 as of Q4 2020. The largest reported holders are Sabby Management, LLC, Griffin Asset Management, Inc., and Captrust Financial Advisors.

Institutional Holders
1
Q4 2020
Reported Value
$579,000
Ticker
unmapped
private placement or foreign
Quarters Tracked
4

Ownership Trend

Institutional holders
Q1 ’20: 1Q1 ’20Q2 ’20: 1Q2 ’20Q3 ’20: 2Q3 ’20Q4 ’20: 1Q4 ’20filingsflow.com
Total reported value
Q1 ’20: $4,000Q1 ’20Q2 ’20: $2,000Q2 ’20Q3 ’20: $634,000Q3 ’20Q4 ’20: $579,000Q4 ’20filingsflow.com

Holders

··Mixed quarters
Export to Excel
Manager% of PortfolioValueSharesQuarter
SABBY MANAGEMENT, LLC$45M AUM0.11%$579,00014.48MQ4 2020
GRIFFIN ASSET MANAGEMENT, INC.$887M AUM0.00%$4,00047.1KQ1 2020OLDER
CAPTRUST FINANCIAL ADVISORS$57.3B AUM0.00%$2,00010.0KQ2 2020OLDER
WENDELL DAVID ASSOCIATES INC$919M AUM0.00%$1,00013.0KQ3 2020OLDER

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.